Selecta Biosciences (SELB) Tops Q4 EPS by 10c

Selecta Biosciences (NASDAQ: SELB) reported Q4 EPS of $0.03, $0.10 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $29.94 million versus the consensus estimate of $17.58 million.

For earnings history and earnings-related data on Selecta Biosciences (SELB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c